Table 1 Clinical samples used in this study, related to Fig. 1
Donor ID | Sex | Age | COVID-19 severity | Sampling day post PCR positivity or onset | Blood collection |
|---|---|---|---|---|---|
KK-003 | Female | 19 | Mild | 2 | 2020/7/21 |
KK-005 | Female | 24 | Mild | 8 | 2020/7/22 |
KK-006 | Female | 38 | Mild | 8 | 2020/7/22 |
KK-007 | Female | 38 | Mild | 20 | 2020/8/26 |
KK-008 | Male | 63 | Mild | 9 | 2020/8/11 |
KK-009 | Male | 36 | Mild | 22 | 2020/8/12 |
KK-010 | Male | 60 | Mild | 17 | 2020/8/14 |
KK-011 | Female | 67 | Moderate | 28 | 2020/8/19 |
KK-012 | Male | 35 | Moderate | 16 | 2020/8/31 |
KK-013 | Male | 72 | Moderate | 11 | 2020/8/31 |
TK-001 | Female | 62 | Mild | 28 | 2020/9/14 |
TK-002 | Male | 60 | Mild | 25 | 2020/10/19 |
TK-003 | Female | 75 | Mild | 28 | 2020/10/26 |
IK-001 | Male | 45 | Mild | 6 | 2020/11/18 |
IK-002 | Male | 42 | Mild | 4 | 2020/11/18 |
IK-003 | Male | 38 | Mild | 109 | 2020/11/18 |
IK-004 | Male | 53 | Moderate | 236 | 2020/12/3 |
IK-005 | Male | 38 | Mild | 128 | 2020/12/7 |
IK-006 | Male | 75 | Moderate | 10 | 2020/12/15 |
IK-007 | Male | 77 | Moderate | 20 | 2020/12/9 |
IK-008 | Male | 33 | Mild | 130 | 2020/12/9 |
IK-009 | Male | 52 | Mild | 118 | 2020/12/15 |
IK-010 | Male | 54 | Moderate | 8 | 2021/1/20 |
IK-011 | Male | 66 | Moderate | 15 | 2021/1/20 |
IK-012 | Male | 72 | Moderate | 8 | 2021/1/20 |
IK-013 | Male | 70 | Moderate | 22 | 2021/1/20 |
IK-014 | Male | 27 | Mild | 41 | 2021/2/16 |
IK-015 | Female | 27 | Mild | 2 | 2021/3/10 |
IK-016 | Male | 27 | Moderate | 68 | 2021/3/26 |
IK-017 | Male | 39 | Mild | 173 | 2021/4/5 |
IK-018 | Male | 48 | Mild | 154 | 2021/5/6 |
